Fabrazyme 5 mg, poudre pour solution à diluer pour perfusion

7680562610034 CH-56261 Puder
Fabrazyme 5 mg, poudre pour solution à diluer pour perfusion
Fabrazyme 5 mg, poudre pour solution à diluer pour perfusion
1 / 2
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Puder
Galenic group
Spray/Puder

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
27/06/2024
Summary of Product Characteristics
Français
27/06/2024
Summary of Product Characteristics
Italien
27/06/2024

Detailed composition

Substance Quantity Type Category
PRC
5.0 MG Substance Wirkstoff (Principe actif)
PRC
- Substance HNIDK
PRC
- Substance HNIDK
PRC
- Substance HNIDK
PRC
1.82 MG Substance HBESI

Reimbursement information

Public price
CHF 536.60
Specialties list
Yes
Generic
No
SL addition date: 01/10/2023

Authorization holder

Sanofi-Aventis (Suisse) SA

1214 Vernier

Authorization information

Swissmedic authorization number
56261
Drug name
Fabrazyme, poudre pour solution à diluer pour perfusion
Galenic form
PULPA
ATC Code
A16AB04
Authorization status
Z
Dispensing category
A
First authorization
25/07/2003
Authorization expiration date
31/12/9999
IT Number
07.14.0.
Domain
Human medicine
Field of application
Enzymersatz-Therapie bei Patienten mit Morbus Fabry

Package details

Description (FR)
FABRAZYME subst sèche 5 mg flac
Description (DE)
FABRAZYME Trockensub 5 mg Durchstf
Market launch
01/09/2020
Narcotic (BTM)
No

Other package sizes (1)

FABRAZYME subst sèche 35 mg flac
1 DUR
GTIN: 7680562610027
View